Molecular Characterization of Treatment Resistance in FLT3 Mutant Pediatric Acute Myeloid Leukemia

被引：0
|
作者：
Mclachlan, Tabitha [1 ,2 ,3 ]
Murray, Heather [1 ,2 ,3 ]
Skerrett-Byrne, David [1 ,2 ,3 ]
Dubois, Oceane [4 ]
Withers, Kaitlin [5 ]
Verrills, Nikki [1 ,2 ,3 ]
Dun, Matthew [1 ,2 ,3 ]
机构：
[1] Univ Newcastle, Prior Res Ctr Canc Res Innovat & Translat, Callaghan, NSW, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW, Australia
[4] Univ La Rochelle, Inst Technol, La Rochelle, France
[5] Univ Newcastle, Sch Biol, Fac Sci & Informat Technol, Reprod Sci Grp, Callaghan, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP13
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 154 - 162
  • [2] Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia
    Hu, Xiaoli
    Chen, Fangyuan
    HEMATOLOGY, 2019, 24 (01) : 651 - 660
  • [3] FLT3 inhibitors for the treatment of acute myeloid leukemia
    Metzelder S.
    Röllig C.
    best practice onkologie, 2018, 13 (4) : 182 - 190
  • [4] OTS167 Inhibits FLT3 Expression in FLT3 Mutant Acute Myeloid Leukemia
    Eisfelder, Bartholomew
    Wynne, Joseph
    Colton, Margert
    Cheng, Jason
    Odenike, Olatoyosi
    Alachkar, Houda
    Stock, Wendy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S239 - S240
  • [5] Characterization of a Novel FLT3 BITE Molecule for the Treatment of Acute Myeloid Leukemia
    Brauchle, Bettina
    Goldstein, Rebecca L.
    Karbowski, Christine M.
    Henn, Anja
    Li, Chi-Ming
    Buecklein, Veit L.
    Krupka, Christina
    Boyle, Michael C.
    Koppikar, Priya
    Haubner, Sascha
    Wahl, Joachim
    Dahlhoff, Christoph
    Raum, Tobias
    Rardin, Matthew J.
    Sastri, Christine
    Rock, Dan A.
    Von Bergwelt-Baildon, Michael
    Frank, Brendon
    Metzeler, Klaus H.
    Case, Ryan
    Friedrich, Matthias
    Balazs, Mercedesz
    Spiekermann, Karsten
    Coxon, Angela
    Subklewe, Marion
    Arvedson, Tara
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1875 - 1888
  • [6] Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
    Staudt, Dilana
    Murray, Heather C.
    McLachlan, Tabitha
    Alvaro, Frank
    Enjeti, Anoop K.
    Verrills, Nicole M.
    Dun, Matthew D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [7] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Bartholomew J. Eisfelder
    Caner Saygin
    Joseph Wynne
    Margaret W. Colton
    Mariafausta Fischietti
    Elspeth M. Beauchamp
    Jason X. Cheng
    Olatoyosi Odenike
    Gail Roboz
    Houda Alachkar
    Wendy Stock
    Blood Cancer Journal, 11
  • [8] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Eisfelder, Bartholomew J.
    Saygin, Caner
    Wynne, Joseph
    Colton, Margaret W.
    Fischietti, Mariafausta
    Beauchamp, Elspeth M.
    Cheng, Jason X.
    Odenike, Olatoyosi
    Roboz, Gail
    Alachkar, Houda
    Stock, Wendy
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [9] Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies
    Zhou, Jianbiao
    Chng, Wee-Joo
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (05): : 90 - 97
  • [10] Molecular Characterization of Flt3 Mutation in Acute Leukemia
    Ramzan, Aamir
    Aamir, Kiran
    Jamali, Anwar Ali
    Memon, Khalil Ahmed
    Memon, Rameez Iqbal
    Bhatti, Irfan Ahmed
    Ahmer, Arslan
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (46A) : 601 - 606
12345